Surgical Robotics Provider PROCEPT BioRobotics' Q3 Earnings Beats Street View, Analyst Optimistic About Upside Potential

PROCEPT BioRobotics (NASDAQ:PRCT) stock is trading on Monday after the company released better-than-expected third-quarter earnings.

The company reported EPS loss of $(0.40), down from $(0.51) a year ago, beating the consensus loss of $(0.49).

The surgical robotics company reported third-quarter sales of $58.4 million, up 66.3% year-over-year, beating the consensus of $53.18 million.

The increase was primarily driven by increased system sales, higher average selling prices, and increased handpiece and other consumable revenue.

U.S. handpiece and consumable revenue for the third quarter of 2024 was $29.6 million, an increase of 74% year over year.

William Blair says the update was promising, especially considering management’s remarks on the possibility of procedural disruptions due to the sales team being temporarily removed from the field ...